The effect of nebulized inhalation of terbutaline combined with budesonide on symptom resolution time and immune function in children with bronchopneumonia
Objective:To explore the effects of nebulized inhalation of terbutaline(TBL)combined with budesonide(BUD)on symptom resolution time and immune function in children with bronchopneumonia.Methods:83 children with bronchopneumonia admitted to our hospital from October 2021 to October 2023 were selected as the study subjects and randomly divided into BUD group(n=42)and TBL group(n=41).The BUD group received BUD nebulization inhalation treatment,while the TBL group received TBL in addition to the BUD group.Compare the clinical efficacy,symptom relief time,immune function,and adverse reactions between two groups.Results:The total clinical effective rate of the TBL group was higher than that of the BUD group(P<0.05).The cough relief time,fever reduction time,shortness of breath relief time,and disappearance time of wet lung rales in the TBL group were shorter than those in the BUD group(P<0.05).There was no significant difference in the levels of IgA,IgM,and IgG between the two groups before treatment(P>0.05).After treatment,all indicators in both groups increased.Compared with the BUD group,the TBL group had higher levels of IgA,IgM,and IgG(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:The combination of TBL and BUD nebulization inhalation has better therapeutic effects,promotes the disappearance of symptoms in children with bronchopneumonia,improves immune function,and is safe.
TerbutalineBudesonideAtomizationBronchopneumoniaSymptom resolution timeImmunologic function
NETL
NSTL
万方数据
